Assembly Biosciences Stock Performance
| ASMB Stock | USD 11.01 0.32 2.99% |
The firm shows a Beta (market volatility) of 1.18, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Assembly Biosciences will likely underperform. At this point, Assembly Biosciences has a negative expected return of -0.42%. Please make sure to confirm Assembly Biosciences' value at risk, rate of daily change, relative strength index, as well as the relationship between the kurtosis and market facilitation index , to decide if Assembly Biosciences performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days Assembly Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's primary indicators remain somewhat strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors. ...more
Actual Historical Performance (%)
One Day Return 2.99 | Five Day Return (2.74) | Year To Date Return (35.80) | Ten Year Return (93.31) | All Time Return (97.09) |
Last Split Factor 1:12 | Last Split Date 2024-02-12 |
1 | FORMER LONGTIME NYS ASSEMBLYWOMAN AILEEN GUNTHER WILL CONSULT FOR THE CENTER FOR DISCOVERY | 03/12/2025 |
2 | Thrivent Refreshes Brand, Leans Into Purpose Where Money Means More | 03/17/2025 |
3 | Rajesh Kumar Appointed Bihar Congress Chief Ahead Of State Assembly Polls | 03/18/2025 |
4 | Assembly Republicans approve sheriffsICE bill | 03/19/2025 |
5 | Tejashwi Yadav Slams Nitish Kumar Over His Earth Will End In 10 Years Remark | 03/20/2025 |
6 | Karnataka Doubles Salaries For Ministers, MLAs Amid Fund Shortage Row | 03/21/2025 |
| Begin Period Cash Flow | 19.8 M |
Assembly |
Assembly Biosciences Relative Risk vs. Return Landscape
If you would invest 1,472 in Assembly Biosciences on December 24, 2024 and sell it today you would lose (371.00) from holding Assembly Biosciences or give up 25.2% of portfolio value over 90 days. Assembly Biosciences is currently does not generate positive expected returns and assumes 3.4716% risk (volatility on return distribution) over the 90 days horizon. In different words, 30% of stocks are less volatile than Assembly, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Assembly Biosciences Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Assembly Biosciences' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Assembly Biosciences, and traders can use it to determine the average amount a Assembly Biosciences' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.1222
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | ASMB |
Estimated Market Risk
| 3.47 actual daily | 30 70% of assets are more volatile |
Expected Return
| -0.42 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.12 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Assembly Biosciences is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Assembly Biosciences by adding Assembly Biosciences to a well-diversified portfolio.
Assembly Biosciences Fundamentals Growth
Assembly Stock prices reflect investors' perceptions of the future prospects and financial health of Assembly Biosciences, and Assembly Biosciences fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Assembly Stock performance.
| Return On Equity | -1.21 | ||||
| Return On Asset | -0.38 | ||||
| Profit Margin | (1.44) % | ||||
| Operating Margin | (1.60) % | ||||
| Current Valuation | (38.88 M) | ||||
| Shares Outstanding | 6.36 M | ||||
| Price To Earning | (10.58) X | ||||
| Price To Book | 2.10 X | ||||
| Price To Sales | 2.47 X | ||||
| Revenue | 28.52 M | ||||
| Gross Profit | (24.33 M) | ||||
| EBITDA | (45.42 M) | ||||
| Net Income | (40.18 M) | ||||
| Cash And Equivalents | 116.69 M | ||||
| Cash Per Share | 2.41 X | ||||
| Total Debt | 3.09 M | ||||
| Debt To Equity | 0.04 % | ||||
| Current Ratio | 8.31 X | ||||
| Book Value Per Share | 4.09 X | ||||
| Cash Flow From Operations | (51.12 M) | ||||
| Earnings Per Share | (6.69) X | ||||
| Market Capitalization | 69.98 M | ||||
| Total Asset | 119.17 M | ||||
| Retained Earnings | (825.92 M) | ||||
| Working Capital | 67.7 M | ||||
| Current Asset | 68.37 M | ||||
| Current Liabilities | 3.4 M | ||||
About Assembly Biosciences Performance
By analyzing Assembly Biosciences' fundamental ratios, stakeholders can gain valuable insights into Assembly Biosciences' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Assembly Biosciences has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Assembly Biosciences has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | (27.44) | (26.07) | |
| Return On Tangible Assets | (0.34) | (0.35) | |
| Return On Capital Employed | (0.64) | (0.67) | |
| Return On Assets | (0.34) | (0.35) | |
| Return On Equity | (1.20) | (1.26) |
Things to note about Assembly Biosciences performance evaluation
Checking the ongoing alerts about Assembly Biosciences for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Assembly Biosciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Assembly Biosciences generated a negative expected return over the last 90 days | |
| Assembly Biosciences has high historical volatility and very poor performance | |
| The company reported the previous year's revenue of 28.52 M. Net Loss for the year was (40.18 M) with loss before overhead, payroll, taxes, and interest of (24.33 M). | |
| Assembly Biosciences currently holds about 116.69 M in cash with (51.12 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.41. | |
| Assembly Biosciences has a poor financial position based on the latest SEC disclosures | |
| Roughly 12.0% of the company shares are held by company insiders | |
| Latest headline from ndtv.com: Karnataka Doubles Salaries For Ministers, MLAs Amid Fund Shortage Row |
- Analyzing Assembly Biosciences' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Assembly Biosciences' stock is overvalued or undervalued compared to its peers.
- Examining Assembly Biosciences' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Assembly Biosciences' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Assembly Biosciences' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Assembly Biosciences' stock. These opinions can provide insight into Assembly Biosciences' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Assembly Stock analysis
When running Assembly Biosciences' price analysis, check to measure Assembly Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Assembly Biosciences is operating at the current time. Most of Assembly Biosciences' value examination focuses on studying past and present price action to predict the probability of Assembly Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Assembly Biosciences' price. Additionally, you may evaluate how the addition of Assembly Biosciences to your portfolios can decrease your overall portfolio volatility.
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |